Published in Gene Therapy Weekly, June 23rd, 2005
According to recent research from Poland, "the aim of our study was to investigate whether apoptin and e4orf4 pro-apoptotic genes, transferred by means of electroporation, were suitable for gene therapy of tumors. The two genes were chosen for our study because the proteins they encode induce apoptosis in transformed cells only."
"MTT and TUNEL tests confirmed that both the synthesized apoptin gene and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.